Access to medicines attracts a great deal of interest from patients, clinicians, and the public and there have been significant advances in drug development in recent years which looks set to continue. Helen Taylor, Programme Realisation Manager for Takeda UK, and Eric Low, Founder of Myeloma UK, discuss the unique challenges around access to combination treatments.
Marie Emms, vice president of site and patient participation at Syneos Health, tells us technology helped increase patient enrolment, improve diversity and inclusion, and boost retention rates for clinical trials after the pandemic. Still, she says a lot needs to be done to continue this upward trajectory.
Patient engagement in pharma is evolving, with some companies doing it better than others. Envision Pharma Group’s Dawn Lobban and Sarah Avent discuss the need to engage with patients at every level for holistic inclusion of the patient voice in order for pharma to become truly patient-centric.